Abstract:Objective:To compare the efficacy and safety of risperidone and chlorpromazine in treatment of first-episode schizo phrenia.Methods:It is a one year naturalistic study.One hundred and eighty-six patients with first-episode of schizophrenia were included who met ICD-10 criteria for schizophrenia or schizophreniform disorder and received integrated treatment(risper- idone or chlorpromazine plus psychosocial education,family psycho-education).There were 131 patients included in the risperi- done group and 55 included in the chlorpromazine group.Written informed consent was obtained from the patients or their legal guardians.Clinical stains was assessed with the Positive and Negative Symptom Scale(PANSS).the Treatment Emergent Symptom Scale(TESS)and the time to the discontinuation of treatment.The Short Form-36(sf-36)was used to assess the quality of life.Results:Thirty-five percent in the rieperdone group partially completed follow-up assessments and 51% in the chlor promazine group did.the difference of the rates between the two groups was significant.Response rate was defined as improvement in PANSS total score of≥50%.The response rates at the end of 2.3.6.8.12 months in the risperidone group were 29.1%.41.8%. 50.9%.50.9%.56.4% and in the chlorpromazine group were 40.5%.46.6%.57.3%.64.1%.62.6%.respectively.There was no significant difference of the response rate at any of the follow up time between the two groups.The relapse rates were similar as 20. 2% in the risperidone group and 20.6% in the comparing group.The time to the discontinuation of treatment for any cause was longer in the risperidone group than in the chlorpromazine gronp.However.the difference was not significant.Risperidone was associated with lower symptoms of tremor,constipation,sialorrhea(P0.01)and also associated with more frequent reports of agitation,de- pression,insomnia,gastrointestinal disturbance,menstrual disorder(P0.05).There are significant improvements in 6 factors (role of physics,body pain.globe health,social function,role of emotion and mental heahh)of sf 36 in risperidone group and only 2 factory(social function,role of emotion)in the comparative group.Conclusion:The efficacy of risperidone is as same as that of chlorpromazine in the treatment of first-episode schizophrenia,yet the rates of some adverse events are different in the two groups and risperidone may enhance the quality of life from more aspects.

Antipsychotic Alone Venus Combined with Psychosocial Intervention on One-Year Outcome in Non-Chronic Schizophrenia

Clinical Study of Psychological Intervention Combined with Antipsychotics for Schizophrenia

Social cognition and interaction training for patients with stable schizophrenia in Chinese community settings

Effect of active intervention of medication compliance on rehabilitation of schizophrenic patients in community

Controlled Trial of the Effectiveness of Community Rehabilitation for Patients with Schizophrenia in Shanghai, China.

Effects of drug attitudes on treatment compliance and psychiatric symptoms of schizophrenia: an one year follow-up study

Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.

Two-stage Integrated Care Versus Antipsychotic Medication Alone on Outcomes of Schizophrenia: One-year Randomized Controlled Trial and Follow-Up

One-year outcome of low-intensity booster sessions versus care as usual in psychosis patients after a short-term psychoeducational intervention

Compliance with antipsychotic treatment and relapse in schizophrenia

Psychotic Symptoms and Attitudes Toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up

Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia

Association Between Symptom Control and Functional Improvement in Patients with Acute Schizophrenia: A Post Hoc Analysis of an Open-Label, Single-Arm, Multi-Center Study of Paliperidone-Extended Release Formulation.

Efficacy of Early Intervention on First-Episode Schizophrenic Patients

One year follow-up study on olanzapine in the treatment of patients with first-episode schizophrenia

Social Skills Training for Patients with Schizophrenia - A Controlled Clinical-Trial

Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial

Socio-Demographic and Clinical Determinants of Quality of Life in Chinese Patients with Schizophrenia: A Prospective Study

One Year Follow-up Study: Risperidone and Chlorpromazine for Patients with First-episode Schizophrenia

12 year follow-up study on the course and outcome of schizophrenia

Effect of Family Intervention on the Prognosis of First-Episode Patients with Schizophrenia